SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $237,237 | +11.9% | 4,925 | -2.6% | 0.00% | – |
Q1 2023 | $212,066 | +6.0% | 5,054 | -3.7% | 0.00% | – |
Q4 2022 | $200,121 | -5.6% | 5,247 | -3.1% | 0.00% | – |
Q3 2022 | $212,000 | -87.0% | 5,416 | -89.0% | 0.00% | -100.0% |
Q1 2022 | $1,627,000 | -23.9% | 49,146 | -2.2% | 0.00% | -33.3% |
Q4 2021 | $2,137,000 | -1.5% | 50,246 | +2.7% | 0.00% | 0.0% |
Q3 2021 | $2,169,000 | -3.5% | 48,946 | +23.8% | 0.00% | 0.0% |
Q2 2021 | $2,247,000 | +29.7% | 39,546 | +70.9% | 0.00% | 0.0% |
Q1 2021 | $1,732,000 | +179.8% | 23,146 | +170.0% | 0.00% | +50.0% |
Q4 2019 | $619,000 | -48.5% | 8,573 | +0.1% | 0.00% | -33.3% |
Q3 2019 | $1,202,000 | -22.7% | 8,565 | +0.8% | 0.00% | -25.0% |
Q2 2019 | $1,555,000 | +50.5% | 8,494 | +30.7% | 0.00% | +100.0% |
Q1 2019 | $1,033,000 | +289.8% | 6,497 | +135.1% | 0.00% | +100.0% |
Q4 2018 | $265,000 | -89.1% | 2,763 | -83.9% | 0.00% | -83.3% |
Q3 2018 | $2,426,000 | -1.2% | 17,175 | +9.5% | 0.01% | 0.0% |
Q2 2018 | $2,456,000 | +622.4% | 15,689 | +642.5% | 0.01% | +500.0% |
Q1 2018 | $340,000 | – | 2,113 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |